Decision on valerian root extract as a supplemental ingredient in foods

Health Canada's Food and Nutrition Directorate has assessed valerian root extract (i.e., extracts of Valeriana officinalis L. root) for use as a supplemental ingredient. This is one of the ingredients that the Food and Nutrition Directorate identified for further assessment, as set out in Health Canada's Category Specific Guidance for Temporary Marketing Authorization: Supplemented Food.Footnote 1

The assessment considered publicly available information, and found the data insufficient to establish acceptable conditions for its use as a supplemental ingredient in supplemented foods.

Consequently, Health Canada is not acceding to the use of valerian root extract as a supplemental ingredient. While valerian root has traditional use as a medicinal tea, and valerian root extract has a history of use as a flavouring in some foods, the available information is insufficient to assess the safety of valerian root extract for use as a supplemental ingredient. The food seller is responsible for ensuring that the sale of a food containing valerian root extract does not contravene section 4 of the Food and Drugs Act.

Health Canada is prepared to accept a request to reconsider this decision under the regulations for supplemented foods. The Appendix of this letter identifies the information required to support reconsideration.

For more information on Health Canada's decision on valerian root extract, please contact the Food and Nutrition Directorate's Submission Management and Information Unit (SMIU) (E-mail: smiu-ugdi@hc-sc.gc.ca). Please use the words "Decision on Valerian Root Extract" in the subject line of your e-mail.

Appendix 1 – Information to support a request for Health Canada to reconsider the decision on the use of valerian root extract as a supplemental ingredient

Note: Health Canada may ask for additional data or other information related to the safety of valerian root extract after reviewing the below information.

General guidance

  1. Characterise in detail the valerian root extract requested for use.
  2. Clearly demonstrate that the toxicological and nutritional safety information apply to use of the requested valerian root extract as a supplemental ingredient in supplemented foods. For example, explain why the results of toxicity testing of a particular valerian root extract apply to such use of the requested valerian root extract.
  3. Provide full study reports of safety tests, not summaries. The reports should provide clear, detailed characterisation of the valerian root extract test material and a full description of the study design, including methods used, the type and number of animals treated, the doses administered and the end-points measured. Studies should also provide detailed documentation of the test results.

Toxicological information

  1. Repeated dose toxicity testing of orally administered valerian root extract at doses that would provide adequate evidence of safety to support its use as an ingredient in foods suitable for consumption by the general population.
  2. Mutagenicity and clastogenicity testing of the valerian root extract. Of special concern is in vivo genotoxicity and germ cell genotoxicity.
  3. Reproductive and developmental toxicity testing of orally administered valerian root extract at doses that would provide adequate evidence of safety to support its use as an ingredient in foods suitable for consumption by the general population, including foods that could be consumed by children and individuals who are pregnant or who are trying to become pregnant.

    In the absence of results from such toxicity testing, Health Canada will also consider a scientifically sound rationale why foods containing valerian root extract would not pose a significant health concern if they were consumed by these sensitive population sub-groups.

  4. Information to characterise the dose in which valerian root extract adversely effects drug metabolising liver enzymes. The available literature suggests that valerian root extract can affect liver enzymes involved with drug metabolism. This could result in food-drug interactions, which may affect the safety and efficacy of some drugs.

Nutritional information

  1. Information on constituents in the valerian root extract that may affect digestion or absorption of other nutrients, especially in the intestines, and/or information on whether these constituents could pose nutritional safety concerns if foods containing valerian root extract were to be consumed frequently over a long period of time in different food matrices.

This information is required to address the safety of valerian root extract for use as a supplemental ingredient in supplemented foods, not to demonstrate efficacy or to support specific health claims. For substantiation of food health claims, please see Health Canada's guidance Substantiation of Health Claims (Scientific Evidence)Footnote 2.

Footnotes

Footnote 1

The ingredients identified for further assessment are listed in Appendix 2 of Health Canada's Category Specific Guidance for Temporary Marketing Authorization: Supplemented Food, February 2016. https://www.canada.ca/en/health-canada/services/food-nutrition/legislation-guidelines/guidance-documents/category-specific-guidance-temporary-marketing-authorization-supplemented-food.html

Return to footnote 1 referrer

Footnote 2

https://www.canada.ca/en/health-canada/services/food-nutrition/legislation-guidelines/guidance-documents/guidance-document-preparing-submission-food-health-claims-2009-1.html

Return to footnote 2 referrer

Page details

Date modified: